Mantovani, Luisa <br/><br/>
Intermediate-dose cytarabine treatment delivered at moderate infusion rates for de novo acute myeloid leukemia-results of a phase I-II study.  [electronic resource] 

 -  Leukemia & lymphoma  Feb 2002 
 - 265-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.1080/10428190290006035  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Algorithms<br/>Cytarabine--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Infusions, Parenteral--methods<br/>Leukemia, Myeloid--complications<br/>Male<br/>Middle Aged<br/>Remission Induction--methods<br/>Stem Cell Transplantation<br/>Survival Analysis<br/>Transplantation, Homologous<br/>Treatment Outcome